Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Bill Peck

Bill Banyai

Twist Bioscience Corporation

AMPLY Discovery leverages evolution and machine learning to discover new drugs through technology that digitizes biological diversity using next-generation sequencing.

AMPLY Discovery

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Austin Che

Tom Knight

Jason Kelly

Barry Canton

Reshma Shetty

Ginkgo Bioworks Holdings, Inc.

Massive Bioinformatics provides bioinformatics and biotechnology solutions aimed at enhancing the quality of life through innovative products and services, self-described as a team of dedicated scientists and software engineers.

Massive Bioinformatics

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. 

Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. 

Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. 

Twitter          @TwistBioscience
Facebook     facebook.com/TwistBioscience
YouTube       youtube.com/TwistBioscience

#WeMakeDNA

Capital World Investors

Kangmei Pharmaceutical

NFT Investment

Reinet Investments S.C.A.

Biomatics Capital Partners

Ditch Plains Capital Management LP

3W Partners

Bay City Capital

Dentsu Ventures

Asset Management Ventures (AMV)

E Squared Capital Management

Twist Bioscience

🧬 If you read one “look back” piece this time of year, this is certainly the one you should read. By Emily Leproust: A 10 Year Leap That Has Changed The World.

Twist Bioscience, #NGS, #DataStorage, #TwistBlog, #DNA

We have a treat for you! Aaron Sato’s talk from #ANTIBODYENG: “Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, & Machine Learning” including super interesting case studies. Check it out: https://lnkd.in/gHeGp9Ci

#antibody #antibodydiscovery #DNA #machinelearning

Don't miss this opportunity to accelerate your experiments with Twist Bioscience’s new Express Genes service! Unlock the door to limitless possibilities and propel your genetic research forward.

Order your Express Genes before capacity runs out: https://lnkd.in/gKR4i9fX

#gene #genes #DNA

Our miniaturization process allows us to write DNA more sustainably than traditional 96 well plate methods. A LOT more…

Learn more here: bit.ly/3QZzkjP

Twist Bioscience, #ESG, #DNA, #gene

Twisters across all sites have been gathering together to celebrate the holidays, end of year, and each other. Our South San Francisco, Wilsonville, and Carlsbad teams had a great time last week dressing up for a night out with snacks, drinks, friends and colleagues!

Wishing you a joyful holiday season and happy New Year! 🎁 🥂

Metric
Company Name	Twist Bioscience Corporation	AMPLY Discovery	Ginkgo Bioworks Holdings, Inc.	Massive Bioinformatics
Symbol	TWST		DNA
MSH ID	COM:TWISTBIOSCIENCE	COM:AMPLYDISCOVERY	COM:GINKGOBIOWORKS	COM:MASSIVEBIOINFORMATICS
Market	STOCKS	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Medical - Diagnostics & Research	Biotechnology	Biotechnology	Biotechnology
Country	US	GB	US	TR
Stage			Grant
Employee Count	919	7	1.22K
Website	twistbioscience.com	amplydiscovery.com	ginkgobioworks.com	massivebioinformatics.com
LinkedIn	twist-bioscience		ginkgo-bioworks
Founders

Metric
Market Cap	2.97B	725.64M
Enterprise Value
Monthly Web Traffic	64.48K	20.69K	833
Web Traffic Growth	-0.15	-0.17	0.18
Valuation
Raised Capital	250M

Metric
Revenue	312.97M	251.46M
Revenue (LTM)
Revenue (NTM)
Gross Profit	133.35M	142.64M
EBITDA	-176.71M	-600.68M
Operating Income	-220.83M	-672.23M
Net Income	-208.73M	-892.87M
EPS	-3.60	-0.46
Diluted EPS	-3.60	-0.46
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.41	0.75
Operating Profit Margin	-0.64	-3.34
EBITDA Margin	-0.56	-2.39
Net Profit Margin	-0.69	-3.55
Return on Equity	-0.32	-0.65
Return on Assets	-0.27	-0.54
Return on Capital Employed	-0.33	-0.51

COM:TWISTBIOSCIENCE

Twist Bioscience

Last Close

41.66

22/11 21:00

Market Cap

2.60B

Beta: -

Volume Today

717.63K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-9.65	-2.78
P/B Ratio	2.91	1.90
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	12.36	93.70
EV Multiple	-10.69	-1.34

Metric
Days Sales Outstanding	77.19	73.17
Days Payables Outstanding	36.14	50.57
Days Inventory Outstanding	66.86	0.27
Operating Cycle	116.05	46.33
Cash Conversion Cycle	97.12	-7.39
Asset Turnover	0.46	0.15

Metric
Operating Cash Flow	-142.47M	-295.50M
Free Cash Flow	-170.25M	-336.30M
Cash Flow to Debt	-0.80	-0.63
Operating Cash Flow/Sales	-0.24	-1.14
Free Cash Flow Yield	-0.10	-0.16

Metric
Cash & Equivalents	226.32M	948.86M
Accounts Receivable	-4.32M	50.07M
Inventory	24.08M	46K
Goodwill	85.81M	49.24M
Debt to Capitalization	0.15	0.35
Debt to Assets	0.11	0.20
Current Ratio	6.79	6.78
Quick Ratio	5.31	5.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.21	0.94
R&D to Revenue	0.55	2.05
SG&A to Revenue		1.32